SANEGENEBIO

SanegeneBio is an emerging RNAi-based company developing innovative RNA interference (RNAi) therapeutics driven by the cutting-edge delivery technology. Founded in 2021, SanegeneBio was propelled by a team of industry-leading experts and has operations in both the US and China... Our proprietary GalNAc LEAD™ platform enables safe, efficient and precise delivery of RNAi drugs to liver tissue, at an international leading level

Also known as: Sanegene Bio USA Inc., Suzhou Sanegene Bio, Suzhou Sanegene Bio Inc

Primary location: Woburn United States